Drug Type AAV based gene therapy |
Synonyms Adeno-associated virus 9 vector expressing a functional human codon optimized cDNA encoding MMAB (NIH/NCATS) |
Target |
Mechanism MMAB modulators(metabolism of cobalamin associated B modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Methylmalonic Acidemia | Preclinical | US | 16 Oct 2024 | |
Methylmalonic Acidemia | Preclinical | US | 16 Oct 2024 |